Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V1512 effervescent tablets versus Sinemet in fluctuating Parkinson's disease
2006-004112-51Phase 3Completed
- Sponsor
- Vernalis
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Sirio and levodopa in Parkinson's disease (PD) (2 arms), sponsored by Vernalis. Primary endpoints: Cmax, Tmax and 7 more. Started Dec 2006; status: completed.
02
Drugs
Siriolevodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2006-004112-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004112-51.